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Enzyme-linked immunosorbent assays (ELISAs) are applied for the quantiﬁcation of a vast diversity of
small molecules. However, ELISAs require that the antigen is present in a soluble form in the sample.
Accordingly, the few ELISAs described so far targeting insoluble proteins such as integral membrane
and scaffold proteins have been restricted by limited extraction efﬁciencies and the need to establish
an individual solubilization protocol for each protein. Here we describe a sandwich ELISA that allows
the quantiﬁcation of a diverse array of synaptic membrane and scaffold proteins such as munc13-1, geph-
yrin, NMDA R1 (N-methyl-D-aspartate receptor subunit 1), synaptic vesicle membrane proteins, and
SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors). The assay is based
on initial solubilization by the denaturing detergent sodium dodecyl sulfate (SDS), followed by partial
SDS removal using the detergent Triton X-100, which restores antigenicity while keeping the proteins
in solution. Using recombinant standard proteins, we determined assay sensitivities of 78 ng/ml to
77 pg/ml (or 74–0.1 fmol). Calibration of the assay using both immunoblotting and mass spectroscopy
revealed that in some cases correction factors need to be included for absolute quantiﬁcation. The assay
is versatile, allows parallel processing and automation, and should be applicable to a wide range of hith-
erto inaccessible proteins.
 2010 Elsevier Inc.Open access under CC BY-NC-ND license.Despite recent advances in quantitative mass spectrometry
(MS)1 [1,2], the quantiﬁcation of individual proteins and peptides
is widely founded on immunoassays that rely on the binding of spe-
ciﬁc antibodies. Since the introduction of radioimmunoassays [3]
and, somewhat later, enzyme-linked immunosorbent assays
(ELISAs), countless variations of quantitative immunoassays have
been developed and standardized [4–6]. Together, these assays have
revolutionized clinical diagnostics by allowing the detectionlogy, Max Planck Institute for
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-NC-ND license.and quantiﬁcation of an increasingly large array of peptide and
nonpeptide biomolecules at high sensitivity in complex biological
samples. To date, however, such assays have been conﬁned largely
to biomolecules that are soluble and, thus, can be easily and selec-
tively captured by immobilized antibodies [7]. In contrast, it is much
more difﬁcult to quantify proteins that are bound to cellular struc-
tures, such as membranes and multiprotein scaffolds, or to insoluble
aggregates/polymers, such as the extracellular matrix [8]. To
measure such proteins by immunoassays, they need to be made
accessible to antibody binding and to be dissociated from the macro-
molecular structure with which they are associated; hence, they
need to be solubilized.
Currently, there is no unifying protocol that allows the nonde-
naturing solubilization of insoluble proteins owing to the fact that
the chemical nature of binding is highly variable. For instance, inte-
gral membrane proteins are usually solubilized by nondenaturing
detergents, resulting in a colloidal solution of mixed micelles of
detergents, including both membrane lipids and proteins. The most
widely used detergent is Triton X-100, a mixture of nonionic sur-
factants composed of polyoxyethylene oxides of variable length
that are linked to the 4-(1,1,3,3-tetramethylbutyl)phenyl group
as hydrophobic moiety [9]. Although this strategy works well for
membrane proteins that are freely mobile in the plane of the mem-
brane, it is inefﬁcient if the proteins are stably anchored to scaffold
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microdomains (‘‘rafts”), and/or if the interactions are mediated pri-
marily by interactions that are not exclusively hydrophobic. The
only universally available reagent effective for solubilizing most
of such complexes is sodium dodecyl sulfate (SDS), a surfactant
with a single negative charge. Although SDS forms mixed micelles
and thus acts as surfactant, its unique features are owed to the fact
that it binds directly to the polypeptide backbone of any protein,
thereby stabilizing the unfolded state on denaturation while pre-
venting aggregation due to the introduction of multiple negative
charges [10]. However, SDS is generally not compatible with anti-
gen–antibody interactions because (i) epitopes are at least partially
destroyed and (ii) not only the proteins to be analyzed but also the
detecting antibodies are denatured.
Considering the versatility of SDS as a general solubilizing
agent, an attractive possibility is to remove SDS after the initial sol-
ubilization so as to restore antigen–antibody interaction. However,
because proteins at best undergo only partial refolding after the re-
moval of SDS, removal usually results in aggregation. Conse-
quently, the only widely used method for immunodetection after
SDS solubilization is immunoblotting (or ‘‘Western” blotting). Here
the proteins are ﬁrst separated by denaturing SDS–PAGE (poly-
acrylamide gel electrophoresis) according to molecular mass and
then transferred to adsorbing membranes while washing out
bound SDS, followed by antibody detection of the immobilized
(and aggregated) protein. Indeed, immunoblotting must currently
be considered as the standard procedure for relative (and occasion-
ally absolute) quantiﬁcation of all proteins for which other immu-
noassays are not available. However, there are several limitations
that so far have prevented its use for widespread and standardized
routine analysis. First, transfer efﬁciency and detection sensitivity
are variable between experiments. Consequently, both standards
and analyzed samples need to be separated on the same gel and
need to be transferred to the same membrane, severely limiting
sample throughput. Second, due to the limitation in the resolving
power of one-dimensional SDS–PAGE, antibody binding to rare
proteins is quenched by more abundant proteins migrating at the
same position, thereby limiting sensitivity and/or increasing the
chance of nonspeciﬁc signals, with the latter being particularly rel-
evant if high-sensitivity detection systems such as enhanced
chemiluminescence are used.
In the current study, we explored the general usefulness of pre-
viously described methods for partial renaturing of SDS-solubilized
proteins [11,12] that prevent aggregation and, thus, allow captur-
ing such proteins with antibodies in solution. It has been known
for many years that the addition of excess Triton X-100 to SDS-con-
taining samples results in SDS capture within mixed micelles; this
not only prevents denaturation of newly added proteins such as
antibodies but also strips SDS from the proteins, at least partially,
and restores secondary structure while preventing aggregation
[13]. As examples, we used a set of synaptic proteins that are either
‘‘free” integral membrane proteins (vesicular glutamate transport-
ers), membrane proteins known to associate with other membrane
proteins (SNAREs [soluble N-ethylmaleimide-sensitive factor
attachment protein receptors] and synaptotagmin 1), membrane
proteins that are tightly bound to protein scaffolds (NMDA R1
[N-methyl-D-aspartate receptor subunit 1] and glycine receptor),
or ‘‘classical” insoluble scaffold proteins (munc13-1 and gephyrin)
[8,14]. We systematically explored solubilization efﬁciency and
preservation of antigen–antibody binding, and we describe a mod-
iﬁed ELISA that is based on antigen capture with speciﬁc mouse
monoclonal antibodies followed by detection with speciﬁc rabbit
antibodies that are then read out by a standard enzyme-linked sec-
ondary antibody. Our results show that with the newly developed
assay, quantiﬁcation of insoluble proteins is possible at a medium-
throughput scale.Materials and methods
Materials
Mouse monoclonal antibody (mAb) and rabbit polyclonal anti-
body (pAb) speciﬁc for the following proteins were used for ELISA
or Western blot in this study (all available from Synaptic Systems,
Göttingen, Germany): gephyrin (mAb 3B11, pAb C-terminal epi-
tope), glycine receptor (mAb GlyR4a, unmodiﬁed and biotinylated),
munc13-1 (mAb 266, pAb N-terminal epitope), NMDA R1 (mAb
M68, pAb 1), SNAP-25 (mAb 71.2, pAb C-terminal epitope), synapt-
otagmin 1 (mAb 41.1, pAb cytoplasmic epitope), VGLUT1 (mAb
317D5, pAb C-terminal epitope), and VGLUT2 (mAb 321A8, pAb
C-terminal epitope). Whole mouse brains from adult (10-week-
old) VGLUT1 knockout mice, embryonic (E18) munc13-1/2 double
knockout mice, and controls were provided by S.M. Wojcik and J.S.
Rhee [15,16], and whole mouse brains from newborn SNAP-25
knockout mice and controls were provided by J.B. Sørensen [17].
SDS–PAGE and Western blot were performed according to stan-
dard protocols (Laemmli SDS gels or NuPage 4–12% Bis–Tris gradi-
ent gels from Invitrogen [USA] and chemiluminescence detection
by FujiFilm BAS-1000 camera). Maxi-Sorb microtiter plates were
obtained from Nunc (Denmark), and secondary antibodies were
obtained from Dianova (Hamburg, Germany) and Bio-Rad (USA).
TMB (tetramethylbenzidine) reagent for the ELISA was prepared
according to Ref. [18].Standard proteins
Recombinant proteins from rat were expressed in Escherichia
coli as His6-tagged proteins and puriﬁed over an Ni2+–NTA (nitrilo-
triacetic acid) afﬁnity resin (Qiagen, Hilden, Germany) or were ex-
pressed as Strep-tagged proteins and puriﬁed over a Strep-Tactin
afﬁnity resin (IBA, Göttingen, Germany) [19]. Both puriﬁcations
were followed by ion exchange chromatography (Äkta System,
GE Healthcare, USA). Only SNAP-25 and synaptotagmin 1 were
puriﬁed as full-length proteins. For the puriﬁcation of full-length
synaptotagmin 1, 10% cholate in the homogenization buffer and
0.01% dodecyl maltoside in the subsequent buffers were used.
The following fragments were used as standard for the other pro-
teins: gephyrin, amino acids 294–736; munc13-1, amino acids 3–
317; NMDA R1, amino acids 17–35 fused to amino acids 660–
811 (complementary DNA [cDNA] was kindly provided by P. See-
burg, Heidelberg, Germany); VGLUT1, amino acids 456–560; and
VGLUT2, amino acids 510–582. Inclusion bodies from E. coli were
solubilized in the presence of 6 M urea. For ELISA, recombinant
proteins were diluted in mouse liver homogenate (or in bovine ser-
um albumin [BSA] for the ubiquitously expressed gephyrin) and
treated with detergent in the same way as the endogenous
proteins.Homogenization and solubilization
To obtain a complete tissue homogenate, brain or liver was
homogenized in phosphate-buffered saline (PBS) with protease
inhibitors by 10 strokes in a Potter–Elvehjem homogenizer
clamped to an overhead stirrer (Eurostar Digital, IKA Labortechnik,
Staufen, Germany) at 2000 rpm. Subcellular fractionation of brain
tissue was carried out according to Refs. [20] and [21]. Brieﬂy, rat
or mouse brain was homogenized in 0.32 M sucrose and 10 mM
Hepes–NaOH (pH 7.4) with protease inhibitors (12 ml/rat brain)
and was centrifuged for 10 min at 800g. The supernatant was cen-
trifuged for 15 min at 9200g. The resulting pellet was washed once
with sucrose buffer, yielding a crude synaptosomal pellet (P2) that
was resuspended in 1.2 ml of sucrose buffer and lysed by the
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tion. Hepes–NaOH buffer was added to a ﬁnal concentration of
10 mM at pH 7.4. After 30 min of incubation, the fraction was spun
at 25,000g for 20 min. The pellet fraction of this centrifugation
(LP1) was used for all initial experiments of the study and is re-
ferred to as synaptic junctional complexes (SJC) because it is en-
riched in presynaptic membranes and presynaptic active zones,
including attached synaptic vesicles, and postsynaptic membranes,
including postsynaptic density (PSD) proteins. Major additional
contaminations include mitochondria and myelin [20]. For the
comparison of ELISA, Western blotting, and iTRAQ (isobaric tag
for relative and absolute quantitation) quantiﬁcation, we used
the supernatant of a 35,000g centrifugation of rat brain homoge-
nate (S1). All brain tissue samples or membrane protein fractions
were solubilized at 3 mg/ml protein in 10 mM sodium phosphate
(pH 7.4), 130 mM NaCl, and 5 mM ethylenediaminetetraacetic acid
(EDTA) containing protease inhibitors and 1.2% SDS (modiﬁed from
Ref. [11]) for 15 min at room temperature and diluted with 5 vol-
umes of ice-cold 1.2% Triton X-100 in PBS. Insoluble content was
pelleted by centrifugation at 100,000g for 30 min and was resus-
pended in SDS sample buffer for further analysis. The supernatant
was either used for immunoprecipitation/ELISA or precipitated by
the addition of 4–6 volumes of acetone (20 C) for further analy-
sis by SDS–PAGE or MS.Immunoprecipitation
Protein G–Sepharose (GE Healthcare) was loaded with 2–4 ll of
ascites or 6 lg of puriﬁed immunoglobulin G (IgG) and was incu-
bated with 100 lg of solubilized SJC overnight at 4 C. Beads were
collected, washed three times with PBS and 0.2% Triton X-100, and
resuspended in 50 ll of SDS sample buffer. Samples of starting
material and supernatant were precipitated by the addition of 3
volumes of acetone (20 C) and were resuspended in an equal
volume of SDS sample buffer before analysis by SDS–PAGE and
Western blot. Nonreducing SDS sample buffer was used if the
molecular weight of the antigen was close to 50 or 25 kDa to avoid
interfering antibody signals.Fig. 1. (A) Detergent extraction of membrane and scaffold proteins from a fraction
enriched in SJC. Here 600 lg of SJC was solubilized at 3 mg/ml in 1.2% SDS and
diluted by the addition of 5 volumes of ice-cold 1.2% Triton X-100 (Tx100). A control
sample treated in parallel but with SDS being omitted is shown for comparison. The
extracts were centrifuged at 100,000g to pellet insoluble material (P). Input and
supernatant (S) were concentrated by acetone precipitation, and all fractions were
resuspended in an equal volume of SDS sample buffer. Samples corresponding to
15 lg of starting material from each fraction were separated by SDS–PAGE,
followed by immunoblotting for the proteins indicated. The blots are representative
of four independent experiments. GlyR, glycine receptor. (B) Immunoprecipitation
after SDS extraction. Here 100 lg of SDS-solubilized SJC was incubated with 2–4 ll
of mouse ascites or 6 lg of puriﬁed IgG and 30 ll of protein G–Sepharose overnight
at 4 C. Beads were washed three times and resuspended in 50 ll of SDS sample
buffer (B). Input and supernatant (S) were concentrated by acetone precipitation.
Samples corresponding to 10–20 lg of input were analyzed by SDS–PAGE/immu-
noblotting. Control incubations were carried out using an unspeciﬁc mouse IgG
fraction (except for GlyR and NMDA R1 where the control contained no IgG). The
blots are representative of at least two independent experiments. The dotted line
indicates that samples were run on the same gel but not in adjacent lanes.Immunoassay
All incubations were performed at room temperature and
700 rpm on a microplate shaker (SSM5, Stuart, UK) unless indi-
cated otherwise. Microtiter plates were coated with 100 ng of goat
anti-mouse IgG in 0.1 M sodium carbonate (pH 9.6) for 3 h and
were blocked with 1% tryptone/peptone (TP) in carbonate buffer
for 1 h. After three washes with Tris-buffered saline (TBS, pH
7.4) containing 0.05% Tween 20 (TBST), the plates were transferred
to 4 C and incubated with mouse mAb diluted in TBST overnight
(75–100 ng/well). On the next day, plates were washed twice
with TBST and twice with the antigen buffer (0.2% Triton X-100,
0.05% TP, and TBS) before the addition of the antigen for 2 h. This
was followed by two washes with the antigen buffer, and one
wash and an incubation with the blocking buffer 0.5% BSA, 0.5%
gelatin, 0.5% TP in TBST for 30 min to minimize unspeciﬁc binding
of the rabbit pAb. The pAb was then added for 1 h as a 1:1000 dilu-
tion in blocking buffer. After three washes, the horseradish perox-
idase (HRP)-coupled goat anti-rabbit detector antibody was
applied for 1 h as a 1:10,000 dilution in blocking buffer. Finally,
the plates were washed three times with TBST and developed with
TMB reagent for 30 min before the reaction was stopped by the
addition of 1 M H2SO4. Absorbance at 450 nm was measured in a
Tecan Genios Pro plate reader with a reference wavelength of
650 nm.Tryptic digestion and iTRAQ labeling
Acetone pellets of solubilized samples were resuspended in
28 ll of RapiGest SF Buffer (Waters, USA) and digested in-solution
by trypsin as described previously [22]. In short, the proteins were
ﬁrst reduced by adding 2 ll of reducing agent (iTRAQ Reagent Kit,
Applied Biosystems, USA). After incubation for 1 h, 1 ll of 200 mM
iodoacetamide was added and vortexed for 20 min. Subsequent
digestion was done by adding trypsin (1:20 trypsin/protein ratio)
dissolved in 100 mM triethylammonium bicarbonate (TEAB) buffer
to each sample. The samples were digested overnight at 37 C
while shaking. The tryptic peptides were then tagged with iTRAQ
reagent according to the manufacturer’s instructions (Applied Bio-
systems). The brain extract and the standard protein mix were
tagged with iTRAQ 116 and 117, respectively. After iTRAQ labeling,
the samples were mixed and acidiﬁed by 5% triﬂuoroacetic acid
(TFA, pH 2.0) and incubated at 37 C for 30 min. The samples were
then centrifuged at 4 C for 30 min at 21,000g to remove the Rapi-
Gest SF.
After digestion, the samples were fractionated on an ICAT SCX
(strong cation exchanger) column according to the manufacturer’s
instructions (Applied Biosystems). Brieﬂy, the iTRAQ-labeled sam-
ples were dissolved in 2 ml of loading buffer (10 mM KH2PO4 in
25% acetonitrile, pH 3.0) and subsequently washed with 1 ml of
loading buffer. The peptides were then step eluted with 500 ll of
a KCl solution (5, 100, 150, 200, 300, 400, 500, 600, 800, and
1000 mM) in 25% acetonitrile (pH 3.0). Each fraction was dried in
Fig. 2. ELISA for insoluble proteins: Assay principle and quantiﬁcation of synaptotagmin 1, an integral membrane protein of synaptic vesicles. (A) Schematic overview of the
procedure (see text for details). Following SDS extraction and the addition of Triton X-100, the samples were incubated on microtiter plates that were coated with goat anti-
mouse IgG and decorated with the capture mAb. Sequential incubations were then carried out as indicated on the right. (B) Standard curve obtained with recombinant full-
length synaptotagmin 1. (C) Analysis of extracts of rat and mouse SJC fractions for synaptotagmin 1. Controls included using an unspeciﬁc rabbit serum (PIS) instead of the
detecting antibody and liver extracts where synaptotagmin 1 is not expressed. The graphs represent a typical experiment with average and standard deviations from
triplicate values. The level of three standard deviations of the background absorbance (3*stdev) is shown to indicate the detection limit.
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salt from the samples prior to MS analysis, the samples were de-
salted on a handmade microcolumn with Poros Oligo R2 RP mate-
rial as described previously [23]. The samples were washed with
70 ll of 0.1% TFA, eluted with 20 ll of 50% acetonitrile in 5% formic
acid, and dried in a vacuum centrifuge.
MS and quantiﬁcation
For liquid chromatography–tandem mass spectrometry (LC–
MS/MS), the dried fractions were redissolved in 10% acetonitrile
and 0.15% formic acid and were analyzed on a Thermo LTQ XL Orbi-
trap (Thermo Fisher Scientiﬁc, Bremen, Germany) coupled to an
Agilent 1100 series LC system (Agilent Technologies, USA). Pep-
tides were separated at a ﬂow rate of 200–300 nl/min on a self-made reversed phase column (C18, Reprosil, Maisch, Germany).
Elution of the peptides was done with a 118-min gradient from
7.5% to 37.5% mobile phase B (80% acetonitrile and 0.15% formic
acid). Peak lists were searched against the NCBI RefSeq database
using the Mascot search engine (version 2.2.04). Mass accuracy
was 10 ppm for the parent ion and 30 ppm for fragment ions.
The peptides were constrained to be tryptic with a maximum of
two missed cleavages. Carbamidomethylation of cysteines was
considered as a ﬁxed modiﬁcation, whereas oxidation of methio-
nine residues was considered as a variable modiﬁcation. Quantiﬁ-
cation was done using Mascot (version 2.2.04). The protein ratio
was calculated as a weighted median ratio where peptides with
scores above 15 were used for quantiﬁcation. Only proteins quan-
tiﬁed with unique peptides and a minimum of three peptides have
been included.
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Solubilization and immunoprecipitation of synaptic proteins
To establish a solubilization protocol for insoluble proteins,
which is compatible with subsequent immunoprecipitation, we
took advantage of the fact that SDS can be ‘‘quenched” by the addi-
tion of cold Triton X-100, partially restoring antigenicity while pre-
venting denaturation of added antibodies [11,12]. For testing, we
analyzed a rat brain fraction enriched in SJC for a panel of synaptic
proteins that are thought to be either free integral membrane pro-
teins (vesicular glutamate transporters), integral membrane pro-
teins participating in protein–protein interactions within the
membrane (the SNARE SNAP-25 and the vesicular Ca2+ sensor syn-
aptotagmin 1), integral proteins linked to protein scaffolds (NMDA
R1 and glycine receptor), or scaffold proteins of the presynaptic ac-
tive zone (munc13-1) or of the PSD (gephyrin) [8,14]. The mem-
brane proteins were treated with SDS at different detergent/
protein ratios, from which we chose 4:1 (w/w) as the minimal
detergent concentration required for complete solubilization. Fol-
lowing Refs. [11] and [13], the extract was diluted with Triton X-
100 at a Triton/SDS ratio of 5:1 (w/w) and was centrifuged to sep-
arate soluble and insoluble content, shown in Fig. 1A compared
with solubilization by Triton X-100 alone. As expected, Triton
alone was not capable of quantitatively extracting scaffold or scaf-
fold-anchored proteins. Similar results were obtained with other
nondenaturing detergents, including octylglucoside, sodium cho-
late, and the zwitterionic detergent SB3-10 (data not shown). In
contrast, all proteins are efﬁciently solubilized by SDS and remain
soluble after the addition of Triton (Fig. 1A).
Next, we screened mouse mAbs for their ability to precipitate
synaptic proteins from the SDS/Triton extract. Using a panel of
37 different mAbs, the samples were incubated overnight with
the solubilized proteins, followed by capture of the immunocom-
plexes by incubation with protein G–Sepharose. Of the 37 mAbs
examined, 29 (78%) resulted in speciﬁc immunoprecipitation of
the respective antigen. Representative experiments are shown in
Fig. 1B. For several proteins, immunoprecipitation was nearly
quantitative (e.g., munc13-1, NMDA R1, VGLUT2, synaptotagmin
1). For others, such as VGLUT1, gephyrin, and SNAP-25, precipita-Table 1












3 ng 2.5 ± 0.1 ng/lg




13 ng Quantiﬁable only in
membrane fraction
82–130
NMDA R1 78 ng/ml
(0.74 nM)
19 ng 4.8 ± 0.2 ng/lg 39–84
SNAP-25 6 ng/ml
(0.25 nM)






37 pg 102 ± 20 pg/lg 87–120
VGLUT1 77 pg/ml
(1 pM)




5 ng Quantiﬁable only in
membrane fraction
76–111
Note. The standard curve of each protein is described by the detection limit, which
was determined as the protein amount corresponding to background absorbance
plus 3-fold standard deviation. In addition, the amount of standard protein corre-
sponding to an absorbance signal-to-noise ratio of 2 (S/N = 2) is given to delineate
the optimal measurable range. Protein expression in adult mouse brain was aver-
aged from at least three experiments. The percentage of spiking recovery indicates
how much of the expected signal increase was obtained by the addition of different
amounts of standard protein to brain extract.tion was not quantitative, although an excess of both antibodies
and protein G–Sepharose was used. Finally, some proteins, such
as the glycine receptor, could not be precipitated by any of the
available antibodies. We also carried out immunoprecipitations
using lower (2.5:1) and higher (10:1) ratios of Triton X-100/SDS,
yielding virtually identical results (not shown). Together, our re-
sults show that effective solubilization and immunoprecipitation
can be achieved with the SDS/Triton extraction protocol, a prere-
quisite for the development of an ELISA.
Development of ELISA for synaptic proteins solubilized by the SDS/
Triton procedure
To establish an assay for quantiﬁcation, we turned to a classi-
cal sandwich immunoassay using two speciﬁc antibodies: aFig. 3. Concentration dependence of the ELISA signal with two different antigens
using puriﬁed standard proteins and membrane extracts. Increasing amounts of SJC
extracts were assayed for NMDA R1 (NR1) (A) and synaptotagmin 1 (Syt1) (B) and
were compared with the signals obtained with recombinant puriﬁed standard
proteins. One of three independent experiments is plotted with the averages and
standard deviations from triplicate values.
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(Fig. 2). Because the commonly applied adsorptive binding of a
protein to a surface is associated with partial denaturation and loss
of function [24], we coated microtiter plates with goat anti-mouse
IgG to allow binding of the capture antibody in an active form. For
measuring the polyclonal detector antibody, goat anti-rabbit IgG
coupled to HRP was added as a secondary detector, thereby avoid-
ing the need for direct coupling of the speciﬁc antibody. Because
proteins may lose antigenicity or aggregate when frozen and
stored as Triton X-100 extracts, the SDS/Triton solubilization was
performed directly before the ELISA. Samples were then diluted
to an appropriate protein concentration and to 0.2% (v/v) Triton
X-100. During development of the ELISA protocol, we found that
most of the background was due to unspeciﬁc binding of the poly-
clonal rabbit serum. We tested the blocking efﬁciency of several
compounds and ﬁnally decided to use a mixture of TP, BSA, and
gelatin because each one performed best for a subset of antigens.
In total, 17 antibody pairs were found to be principally suitable
for the quantiﬁcation of synaptic proteins using our ELISA protocol.
Of these 17 antibody pairs, 7 were selected for further standardiza-
tion (Table 1), as exempliﬁed for synaptotagmin 1 in Fig. 2. For cal-
ibration, recombinant synaptotagmin 1 (Fig. 2B) was diluted in
liver extracts to approximate the sample complexity of the brain
extracts. As can be seen from the ﬁgure, a nearly linear dependence
of the signal on the amount of synaptotagmin was observed over a
100-fold measuring range, with the detection limit being 0.24 ng/
ml. To control for the speciﬁcity of the detection, preimmune rab-
bit serum was used (Fig. 2C). As a negative control, we used ex-
tracts from rat liver (where synaptotagmin is not expressed) that
were processed in parallel. In addition, extracts from knockout
mice were tested if available (SNAP-25 and VGLUT1) and did not
show a signal response above background (data not shown).
For each of the seven antibody pairs, we optimized antibody
concentrations and determined the average detection limit for
the puriﬁed recombinant standard proteins. Intraassay variation
coefﬁcients of the standard curve in the working range were gen-
erally below 10%, whereas interassay variation coefﬁcients were
between 2% and 20%. VGLUT2 and munc13-1 did not show a linear
dose–response when brain homogenate was used as starting sam-
ple. Thus, these proteins could be accurately measured only in en-
riched membrane preparations (data not shown). To further test
whether the tissue extracts contained factors interfering with the
detection of the proteins, we performed internal standardization
using the recombinant proteins. The amounts of the standard pro-
teins were adjusted to be within the measuring range of the assayFig. 4. Comparison of ELISA with Western blot (SNAP-25). Puriﬁed recombinant SNAP-25
in parallel by SDS–PAGE and immunoblotting, followed by densitometry (B) as well as b
units. The blots used for panel B are shown in panel C.and were mixed with the tissue extracts. As shown in Table 1, sig-
nal recoveries for most proteins were high but variable, ranging
from 60% to 140%. Exceptions include NMDA R1 and SNAP-25,
where recoveries were lower, suggesting that antibody binding
to the recombinant protein is partially shielded by interfering com-
ponents present in the brain extract (Table 1). Moreover, we ob-
served that in some cases the standard proteins had a higher
linear range and yielded much higher signals at saturation than
those obtainable by the extracts (Fig. 3). Although some improve-
ment was observable when the concentration of detergent in the
antigen buffer or the concentration of the speciﬁc pAb was in-
creased, a 2-fold (or larger) difference remained (data not shown).
Intriguingly, such deviation was seen only when the recombinant
standard protein represented only a fragment of the native protein.
In contrast, the ELISAs for synaptotagmin 1 and SNAP-25, for which
recombinant full-length proteins were used as standard, did not
show this behavior (Fig. 3) (see Discussion).
Comparison with other quantiﬁcation techniques and possible
applications
To further validate the ELISA quantiﬁcation, we analyzed the
same sample in parallel by ELISA, Western blotting, and quantita-
tive MS following isobaric labeling of standard and test samples
(Fig. 4and Table 2). Western blotting is commonly used for relative
quantiﬁcation and occasionally absolute quantiﬁcation, depending
on the (frequently not validated) assumption that there is no inter-
ference by sample factors after SDS–PAGE and transfer. Further-
more, sample concentrations need to be adjusted to ensure that
the signals are in the linear range of the detection system. Isobaric
labeling by iTRAQ reagents is based on chemical tagging of the
(tryptic) peptides derived from different samples with speciﬁc iso-
baric tags (e.g., iTRAQ 116 and 117) that are subsequently mixed
and analyzed by LC–MS/MS [2]. Along with the fragmentation,
the tags are split and release characteristic reporter ions, whose ra-
tios can be accurately measured for each peptide in the MS/MS
spectrum.
Six standard proteins were combined in one mastermix stan-
dard and employed to determine the concentration of a rat brain
preparation (S1). Both standard and sample were solubilized and
either used directly for ELISA or precipitated for Western blotting
and iTRAQ labeling. Despite the large complexity of the sample,
three of the endogenous proteins (NMDA R1, SNAP-25, and synapt-
otagmin 1) could be quantiﬁed by iTRAQ. Again, the analysis re-
vealed differences for different proteins. For NMDA R1, the ELISAand rat brain extract were measured by ELISA (A). The same samples were analyzed
y iTRAQ labeling followed by two-dimensional LC–MS/MS (Table 2). A.U., arbitrary
Table 2
Comparison of quantiﬁcation by ELISA, Western blot, and iTRAQ labeling
ng/lg Total protein ELISA iTRAQ Western blot
NMDA R1 2.8 ± 0.5 3.4 7.9 ± 0.7
SNAP-25 0.69 ± 0.09 3.8 ± 0.6 3.9 ± 0.9
Synaptotagmin 1 0.38 ± 0.07 1.4 ± 0.2 1.8 ± 0.7
Note. The concentration of three proteins in rat brain S1 was determined by nor-
malization to a standard protein mastermix. Aliquots of the same samples were
processed for each technique. Values were obtained as averages and standard
deviations of serial dilutions within the working range of the standard curve (n = 2–
5 [see Fig. 4]). In the case of NMDA R1, the protein could only be quantiﬁed from
one dilution by MS. The absolute values are given as ng of the full-length protein
(NMDA R1, SNAP-25, or synaptotagmin 1) per lg of total protein (ng/lg total
protein).
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ues were approximately 2-fold higher. In contrast, for SNAP-25 and
synaptotagmin 1, the ELISA values were several times lower than
those determined by the other methods (Fig. 4 and Table 2) and,
therefore, would need to be multiplied by factors of 5.5 and 3.7,
respectively, to obtain absolute quantiﬁcation.
Because expression proﬁling is a routine element of knockout
mouse analysis, we applied our protocol to measure relative pro-Fig. 5. Quantiﬁcation by ELISA of synaptotagmin 1 and gephyrin in mouse brain. One of t
from triplicate values.tein expression and compare mouse brain samples (Fig. 5). When
synaptotagmin 1 expression was assayed in embryonal and adult
brain homogenate, average values obtained from two experiments
were 6 ± 2 pg/lg in embryonal brain and 102 ± 20 pg/lg in adult
brain, revealing a 17-fold increase during development. In contrast,
gephyrin expression did not differ between embryonal and adult
ages because the average expressions from two experiments were
2.1 ± 0.6 ng/lg for embryonal brain and 2.5 ± 0.1 ng/lg for adult
brain. To investigate whether our sandwich antibody pairs would
be suitable for a multiplexed assay, we used the same brain extract
sample to detect six proteins successively in variable order (Fig. 6).
Regardless of the position of the protein in the series, the absor-
bance level reached at least 80% of the initial signal, demonstrating
that each antibody pair causes only minimal disturbance of the
other measurements, thereby enabling efﬁcient use of samples.Discussion
Despite rapid advances in high-throughput proteomics, quanti-
ﬁcation of proteins in complex samples has remained a major
bottleneck for systems biology. Although isotope labeling com-
bined with MS/MS analysis holds the potential for ﬁlling this gaphree independent experiments is plotted with the averages and standard deviations
Fig. 6. Sequential measurement of six different antigens in the same sample. (A)
Scheme of setup. Six different capture antibodies were coated on a microtiter plate
as indicated. SJC extract was applied to columns 1 and 2 for 30 min and were
successively transferred to columns 3 and 4, columns 5 and 6, and so forth. On a
second microtiter plate, the order of antibodies was inverted. After development,
values for each incubation were averaged from both plates and normalized to the
signal obtained in the ﬁrst incubation (ag-1). Plots for munc13-1 (B) and NMDA R1
(C) show the results from two independent experiments.
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ison of few samples, requires access to modern MS facilities withcutting-edge instrumentation, and is likely to depend on the avail-
ability of mass-tagged peptide libraries for standardization [26,27].
In particular, the analysis of insoluble proteins, such as membrane
and scaffold proteins, has been lagging behind. For instance, until
recently, membrane proteins have been vastly underrepresented
in proteomic analyses of complex biological samples (see, e.g.,
Ref. [14] for a discussion), thereby frequently leavingWestern blot-
ting as the only alternative for qualitative and (semi)quantitative
detection of such proteins.
Thus, the ELISA procedure developed in this study ﬁlls a gap in
the analytical repertoire for insoluble proteins, considerably
extending the capacity and reducing sample amounts in compari-
son with previous methods such as Western blotting. Previous
studies of ELISA in a similar direction [6,28–30] either did not
examine solubilization efﬁciency or established a particular extrac-
tion protocol for each protein, whereas we have presented a uni-
versal procedure suitable for different types of proteins. We
focused speciﬁcally on ‘‘difﬁcult” proteins, that is, proteins that
are membrane-anchored by single or multiple transmembrane do-
mains (VGLUTs, NMDA R1, and synaptotagmin), part of stable and
insoluble protein scaffolds (NMDA R1, gephyrin, and munc13-1), or
associated with other proteins in complexes of very high stability
(SNAP-25). The selection of these proteins was also motivated by
our interest in synaptic function. Accordingly, the set includes rep-
resentative proteins of synaptic vesicles, the presynaptic active
zone, postsynaptic receptors, and postsynaptic scaffold proteins
[8,14], thereby allowing the monitoring of multiple synaptic
parameters in a single assay.
For assay development, we originally favored direct ﬂuorescent
labeling of tissue extracts followed by capture of the antigens using
single speciﬁc antibodies, a strategy commonly used for chip-based
assays with protein arrays (antibodies in this case). However, this
approach turned out to be not feasible because of high unspeciﬁc
background (unpublished observations). Therefore, we resorted
to a classical sandwich ELISA (Fig. 2) and successfully adapted
the method for 17 antibody pairs. To enable convenient handling,
all incubations were adjusted so that the assay can be carried out
in less than 2 days. The assay sensitivity varied between individual
proteins, ranging from tens of ng/ml to tens of pg/ml (or 74–0.1
fmol per well), which generally agrees with ELISAs for soluble anti-
gens [4]. To our knowledge, NMDA R1 is the only protein of the set
studied here for which a comparable assay has been published,
with longer incubation times and a higher sensitivity being re-
ported [29].
The systematic investigation of variables allows a comprehen-
sive assessment of both the advantages and limitations of the
new procedure. Although the sandwich assay itself largely follows
standard protocols (except for the need to use detergents) [4], sam-
ple preparation and sample complexity turned out to be critical
factors. The following conclusions can be drawn. First, the combi-
nation of SDS extraction followed by quenching of SDS by excess
Triton X-100 appears to be generally applicable for (i) solubilizing
proteins that otherwise are nonextractable and (ii) recovering anti-
genicity after SDS quenching while keeping the proteins in solu-
tion. Recovery of antigenicity after SDS denaturation is not
surprising given that Western blotting is based on the same prin-
ciple. Our ﬁnding that most proteins can be immunoprecipitated
from such extracts was a prerequisite for the development of a
capture assay. However, our data also show that some proteins
cannot be completely recovered by immunoprecipitation even if
saturating amounts of antibody are used (e.g., SNAP-25, VGLUT
[see Fig. 2]), and in rare cases no immunoprecipitation was obser-
vable. Thus, it is mandatory to carry out such an initial character-
ization for each new protein to be analyzed by this procedure.
Second, our internal standardization experiments revealed that
protein recovery is generally high, showing that after solubilization
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complexation or aggregation that could mask antigen accessibility
taking place. The lower recovery of SNAP-25 can be easily ex-
plained by the ability of this protein to form stable SNARE com-
plexes that are resistant to SDS [31] and in which the SNAP-25
epitope is masked [32].
Third, caution needs to be exerted in extrapolating the measur-
ing range from the standard to the sample. We found that in some
cases the signals obtainable from complex extracts saturate at
much lower levels than the recombinant standard proteins. It is
possible that antigen accessibility is different if a recombinant
fragment is used as standard. And although we applied the stan-
dard as a mixture with liver homogenate to imitate the matrix con-
ditions of the sample, we cannot exclude brain-speciﬁc
interactions shielding the endogenous protein, thereby lowering
the detection range of the assay.
Finally, our data show that particular care needs to be applied if
not only comparison of parallel samples will be carried out (rela-
tive quantiﬁcation) but also the absolute amounts of the proteins
need to be determined (absolute quantiﬁcation). Our examples
show that even internal standardization (generally considered to
be sufﬁcient for quantiﬁcation) does not safeguard against a signif-
icant underestimation of the total amount. Again, it appears that
the conditions are different for each protein, requiring at least ini-
tial calibration of the assay against other methods using a deﬁned
set of standards that then allow determination of a correction fac-
tor. In fact, this often overlooked problem is inherent to all anti-
body-based assays.
To our knowledge, this is the ﬁrst description of an ELISA
detecting multiple membrane and scaffold proteins in raw tissue
extracts. The assay is highly reproducible, is easy to handle because
it requires only standard equipment for ELISAs, allows medium-
scale throughput, and is suitable for both relative and absolute
quantiﬁcation. As in all assays of this kind, each new antigen and
each antibody pair need to be carefully evaluated and compared
with standards, but we are conﬁdent that the assay can easily be
expanded to a large array of insoluble proteins.
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